EUVIMEDEUVIMED entdecken
Crossref

Risks of maternal cardiopulmonary events associated with ritodrine for tocolysis: A national database linkage study in 1 831 564 pregnant women

Chih-Wan Lin, K Arnold Chan, Yi-Yung Chen, Wei-I Huang, Pi-Hui Chao, Hsun-Yin Liang, Wen-Wen Chen, Fei-Yuan Hsiao iD

International Journal of Gynecology & Obstetrics · 2024

DOI: 10.1002/ijgo.15549 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, 2024. Verfasst von Chih-Wan Lin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Taiwan Drug Relief Foundation, Taipei, Taiwan. Hauptthemen laut MEDLINE: Ritodrine, Pulmonary Edema, Tocolytic Agents, Databases, Factual. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Taiwan Food and Drug Administration, Food and Drug Administration.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Real‐world data on cardiopulmonary events among pregnant women receiving β‐agonist therapy are scarce. In the present study, we aimed to examine the absolute and relative risks of maternal cardiopulmonary events associated with the use of β‐agonist ritodrine during pregnancy.

Methods

By linking Taiwan's National Birth Certificate Application Database with National Health Insurance data, 1 831 564 pregnancies at ≥20 weeks' gestation were identified. Age‐standardized incidence rates of cardiopulmonary events among pregnant women exposed to ritodrine were estimated. Nested case–control analyses were conducted to evaluate the relative risk of pulmonary edema, heart failure, and arrhythmia associated with prior ritodrine use. Cases and controls were matched using risk set sampling, and adjusted odds ratios were estimated using conditional logistic regression models.

Results

A total of 189 cases of pulmonary edema, 126 cases of heart failure, and 162 cases of arrhythmia were identified (corresponding age‐standardized incidence rates: 20.90, 8.35, and 16.63 per 100 000 among pregnant women only exposed to oral ritodrine; 91.28, 36.01, and 14.61 per 100 000 among those ever exposed to intravenous ritodrine). Exposure to oral ritodrine was associated with a lower increased risk of pulmonary edema (aOR 1.76; 95% CI: 1.12–2.76) and arrhythmia (2.21; 1.47–3.32) whereas exposure to ritodrine injection was associated with a significantly higher risk of pulmonary edema (10.56; 6.39–17.45), arrhythmia (4.15; 1.99–8.64), and heart failure (5.58; 2.27–13.74).

Conclusions

Pregnant women receiving intravenous ritodrine therapy had higher cardiopulmonary risks and should be intensively monitored. While the relative risk associated with oral ritodrine is not pronounced, it should be used judiciously among pregnant women as well.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RitodrinePulmonary EdemaTocolytic AgentsDatabases, FactualHumansFemalePregnancyAdultTaiwanCase-Control StudiesHeart FailureArrhythmias, CardiacIncidenceTocolysisYoung AdultRisk Factors

Stichwörter der Autor:innen

maternal cardiopulmonary eventspregnant womenpreterm labortocolysisβ‐Adrenergic agonist

Substanzen

RitodrineTocolytic Agents

Autor:innen und Institutionen

  • Taiwan Drug Relief Foundation, Taipei, Taiwan.
  • Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Health Data Research Center, National Taiwan University, Taipei, Taiwan.
  • Division of High-risk Pregnancy, Department of Obstetrics and Gynecology, Mackay Memorial Hospital, Taipei, Taiwan.
  • School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Department of Pharmacy, National Taiwan University Hospital, Taipei, Taiwan.

ORCID-Profile: Fei-Yuan Hsiao

Förderung

  • Taiwan Food and Drug Administration
  • Food and Drug Administration

Zitieren

APA

Lin, C. W., Chan, K. A., Chen, Y. Y., Huang, W. I., Chao, P. H., Liang, H. Y., Chen, W. W., & Hsiao, F. Y. (2024). Risks of maternal cardiopulmonary events associated with ritodrine for tocolysis: A national database linkage study in 1 831 564 pregnant women. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.15549

Vancouver

Lin CW, Chan KA, Chen YY, Huang WI, Chao PH, Liang HY, et al. Risks of maternal cardiopulmonary events associated with ritodrine for tocolysis: A national database linkage study in 1 831 564 pregnant women. International Journal of Gynecology & Obstetrics. 2024. doi:10.1002/ijgo.15549

BibTeX
@article{Lin2024,
  author = {Lin, Chih-Wan and Chan, K Arnold and Chen, Yi-Yung and Huang, Wei-I and Chao, Pi-Hui and Liang, Hsun-Yin and Chen, Wen-Wen and Hsiao, Fei-Yuan},
  title = {Risks of maternal cardiopulmonary events associated with ritodrine for tocolysis: A national database linkage study in 1 831 564 pregnant women},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2024},
  doi = {10.1002/ijgo.15549}
}
Kostenlos starten →